MedPlus Health Services Limited IPO
MedPlus Health Services Limited was a mainboard IPO in the Pharmacy Retail sector, offered at ₹780–₹796 per share to raise ₹1,398 crore. The issue was subscribed 52.59× overall (QIBs 111.89×, NIIs 85.33×, retail 5.23×). It listed on 23 Dec 2021 at ₹1,040 and closed its first day at ₹1,121, a listing gain of +40.9% versus the ₹796 issue price. It now trades around ₹580 (-27.1% versus the issue price).
Frequently asked questions
- How many times was the MedPlus Health Services Limited IPO subscribed?
- The MedPlus Health Services Limited IPO was subscribed 52.59× overall — 111.89× in the QIB category, 85.33× among non-institutional investors, 5.23× in retail.
- What were the MedPlus Health Services Limited IPO listing gains?
- MedPlus Health Services Limited listed on 23 Dec 2021 at ₹1,040, closing its first day at ₹1,121 — a listing gain of +40.9% versus the ₹796 issue price.
- What were the retail allotment odds for the MedPlus Health Services Limited IPO?
- Retail was subscribed 5.23×, so a single-lot application had roughly a 19.1% chance of allotment (about 1 in 5), and allotment was finalised on 17 Dec 2021.
- What was the price band and lot size of the MedPlus Health Services Limited IPO?
- The price band was ₹780–₹796 per share, with a minimum lot of 18 shares (₹14,328 at the upper band).
- Who were the registrar and lead manager for the MedPlus Health Services Limited IPO?
- KFin Technologies Private Limited was the registrar, and Axis Capital was the book-running lead manager.